Astle Christopher bought ZYME
January 5, 2024 · Form 4 insider transaction
Astle Christopher bought 30,000 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderAstle Christopher
RoleOfficer
CompanyZymeworks Inc. (ZYME)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJanuary 5, 2024
Filing dateJanuary 8, 2024
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.; The RSUs vest in three equal annual installments beginning on January 5, 2025.